Veltassa Powder, For Suspension
Product Images NDC 53436-252

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Veltassa (NDC 53436-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vifor Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Veltassa 01)

The text appears to be discussing the composition of a polymeric network containing calcium-sorbitol counterion and patiromer anion. It specifies the number of 2-fluoro-2-propenoate groups and crosslinking groups present in the network. The symbol "*" indicates that the network is extended.*

FDA Label Image

Figure 2 (Veltassa 02)

This appears to be a table of pharmacokinetic parameters, including the geometric mean ratio and 90% confidence intervals for various drugs compared to a reference drug. The table includes information on the AUC and Cmax for each drug.*

FDA Label Image

Figure 3 (Veltassa 03)

Mean serum potassium levels were recorded at different time points during a study visit. The values obtained were 60, 55, 50, and "a5". The baseline serum potassium level was between 5.1 to 5.5 mEq/L, whereas the baseline value for serum K' was between 6.5 to 6.6 mEq/L. No other information or context is available to provide any further description.*

FDA Label Image

Figure 4 (Veltassa 04)

FDA Label Image

Principal Display Panel (8.4 g Packet Carton)

Veltassa is an oral suspension medication used to treat high levels of potassium in the blood. Each packet contains 8.4 grams* of patiromer and is dispensed as a 30 pack supply with 1 scoop per day. The medication should be used within three months of opening and should be kept in a dry place at room temperature or in the fridge. The medication should be mixed with water and taken immediately as directed by a physician. It should be stored out of reach of children. *Equivalent to a nominal amount of 16.8 grams of patiromer powder to be used as directed by a physician. See prescribing information for more details.*

FDA Label Image

Principal Display Panel (16.8 g Packet Carton)

FDA Label Image

Principal Display Panel (25.2 g Packet Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.